TiumBio Co., Ltd. (KOSDAQ:321550)

TiumBio Revenue

TiumBio had revenue of 4.48B KRW in the quarter ending June 30, 2026, with 71.33% growth. This brings the company's total for the last twelve months to 15.00B, up 104.49% year-over-year. In the year 2025, TiumBio had annual revenue of 12.29B with 80.92% growth. That makes TiumBio the 36,894th largest company in the world by revenue and 2,353rd in South Korea.

• Revenue (ttm): 15.00B
• Revenue Growth: +104.49%
• P/S Ratio: 7.19
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 107.84B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Biopharmaceutical Development and Production 7.38B 60.1%
• Natural Cosmetics 4.91B 39.9%

Fiscal year ended Dec 31, 2025 See the full TiumBio breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	12.29B	5.50B	80.92%
Dec 31, 2024	6.79B	1.89B	38.65%
Dec 31, 2023	4.90B	-4.22B	-46.27%
Dec 31, 2022	9.12B	9.06B	15,952.75%
Dec 31, 2021	56.80M	-992.15M	-94.59%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error